◀ Back to ATP5O
ATP5O — CCL2
Text-mined interactions from Literome
Teshima et al., Int Arch Allergy Immunol 2000
:
Effect of Ca ( 2+ )
ATPase inhibitors on
MCP-1 release from bone marrow derived mast cells and the involvement of p38 MAP kinase activation ... The
effect of two Ca ( 2+ )
ATPase inhibitors, cyclopiazonic acid (CPA) and 2,5-di- ( tert-butyl ) -1,4-hydroquinone ( DTBHQ ), on the release of
MCP-1 from bone marrow derived mast cells ( BMMCs ) were investigated ... These Ca ( 2+ )
ATPase inhibitors
induced MCP-1 release in the absence of phorbol ester, in contrast to their induction of TNF-alpha
Onose et al., Immunol Lett 1998
:
Ca2+-ATPase inhibitor
induces IL-4 and
MCP-1 production in RBL-2H3 cells ... The
effects of a Ca2 ( + )
-ATPase inhibitor, cyclopiazonic acid (CPA), and two hydroquinone-antioxidants, 2,5-di- ( tert-butyl ) -1,4-hydroquinone ( DTBHQ ) and 2,5-di- ( tert-amyl ) -1,4-hydroquinone ( DTAHQ ) on the release of IL-4 and
MCP-1 from RBL-2H3 cells were investigated